Search results
Results from the WOW.Com Content Network
Guidelines on the choice of agents and how best to step up treatment for various subgroups in hypertension (high blood pressure) have changed over time and differ between countries. A Comparison of International Guidelines on Goal Blood Pressure and Initial Therapy for Adults With Hypertension (adapted from JNC 8 guidelines [ 1 ] )
Antiplatelet therapy with one or more of these drugs ... This is known as "dual antiplatelet therapy" (or DAPT). ... (defined in the 2014 ACC/AHA guidelines as ...
Guidelines for treating resistant hypertension have been published in the UK [45] and US. [46] It has been proposed that a proportion of resistant hypertension may be the result of chronic high activity of the autonomic nervous system, known as "neurogenic hypertension". [47] Low adherence to treatment is an important cause of resistant ...
Blood pressure measurements can be influenced by circumstances of measurement. [10] Guidelines use different thresholds for office (also known as clinic), home (when the person measures their own blood pressure at home), and ambulatory blood pressure (using an automated device over a 24-hour period).
Therefore, to reduce stress and anxiety, reduction to smoking and alcohol, decreasing intake of salt or having regular aerobic activity are some examples of therapy that can help manage cases of labile hypertension. By reducing alcohol intake, the systolic blood pressure will lower by 2-4mm Hg and the diastolic blood pressure by 1–2 mm Hg.
Essential hypertension (also called primary hypertension, or idiopathic hypertension) is a form of hypertension without an identifiable physiologic cause. [1] [2] It is the most common type affecting 85% of those with high blood pressure. [3] [4] The remaining 15% is accounted for by various causes of secondary hypertension. [3]
She received treatment at the scene and was transported to a local hospital. Multiple burn victims were also reported “walking toward a nearby restaurant” at about 9 p.m., according to Scott.
The Systolic Blood Pressure Intervention Trial (SPRINT) is a multi-center clinical trial that was performed from 2010 to 2015, and published in November 2015. [1]The objective of the trial was to identify whether, in patients with a systolic blood pressure (SBP) of 130 mm Hg or higher and an increased cardiovascular risk, but without diabetes, treating to a systolic blood pressure target of ...